BIOMAT Database Logo BIOMAT Database Logo

Pharmacokinetics of sibutramine hydrochloride in Chinese healthy volunteers. 2003

Jun Chen, and Wei Lu, and Xin-guo Jiang, and Zheng-xing Rong, and Xia Huang, and Hong-zhuan Chen
Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai 200032, China.

OBJECTIVE To evaluate the pharmacokinetic profiles of the pharmacologically active primary amine metabolite of sibutramine, N-di-desmethyl sibutramine (BTS 54505) in Chinese origin. METHODS According to a randomized cross-over design, a single oral dose of 20 mg of sibutramine hydrochloride capsule was given to 20 healthy Chinese young volunteers. After dosing, serial blood samples were collected for a period of 72 h. BTS 54505 concentration in plasma was analyzed by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry. RESULTS Various pharmacokinetic parameters including AUC0-t, AUC0-infinity, Cmax, Tmax, T1/2, Kelm and MRT were determined for both test and reference capsules and found to be in good agreement with literature values. CONCLUSIONS The test and reference sibutramine capsules were bioequivalent.

UI MeSH Term Description Entries
D008297 Male Males
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003503 Cyclobutanes Four carbon cycloparaffin cyclobutane (the structural formula (CH2)4) and its derivatives.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D017367 Selective Serotonin Reuptake Inhibitors Compounds that specifically inhibit the reuptake of serotonin in the brain. 5-HT Uptake Inhibitor,5-HT Uptake Inhibitors,5-Hydroxytryptamine Uptake Inhibitor,5-Hydroxytryptamine Uptake Inhibitors,SSRIs,Selective Serotonin Reuptake Inhibitor,Serotonin Reuptake Inhibitor,Serotonin Reuptake Inhibitors,Serotonin Uptake Inhibitor,Serotonin Uptake Inhibitors,Inhibitors, 5-HT Uptake,Inhibitors, 5-Hydroxytryptamine Uptake,Inhibitors, Serotonin Reuptake,Inhibitors, Serotonin Uptake,Reuptake Inhibitors, Serotonin,Uptake Inhibitors, 5-HT,Uptake Inhibitors, 5-Hydroxytryptamine,Uptake Inhibitors, Serotonin,Inhibitor, 5-HT Uptake,Inhibitor, 5-Hydroxytryptamine Uptake,Inhibitor, Serotonin Reuptake,Inhibitor, Serotonin Uptake,Reuptake Inhibitor, Serotonin,Uptake Inhibitor, 5-HT,Uptake Inhibitor, 5-Hydroxytryptamine,Uptake Inhibitor, Serotonin
D018592 Cross-Over Studies Studies comparing two or more treatments or interventions in which the subjects or patients, upon completion of the course of one treatment, are switched to another. In the case of two treatments, A and B, half the subjects are randomly allocated to receive these in the order A, B and half to receive them in the order B, A. A criticism of this design is that effects of the first treatment may carry over into the period when the second is given. (Last, A Dictionary of Epidemiology, 2d ed) Cross-Over Design,Cross-Over Trials,Crossover Design,Crossover Studies,Crossover Trials,Cross Over Design,Cross Over Studies,Cross Over Trials,Cross-Over Designs,Cross-Over Study,Crossover Designs,Crossover Study,Design, Cross-Over,Design, Crossover,Designs, Cross-Over,Designs, Crossover,Studies, Cross-Over,Studies, Crossover,Study, Cross-Over,Study, Crossover,Trial, Cross-Over,Trial, Crossover,Trials, Cross-Over,Trials, Crossover
D019540 Area Under Curve A statistical means of summarizing information from a series of measurements on one individual. It is frequently used in clinical pharmacology where the AUC from serum levels can be interpreted as the total uptake of whatever has been administered. As a plot of the concentration of a drug against time, after a single dose of medicine, producing a standard shape curve, it is a means of comparing the bioavailability of the same drug made by different companies. (From Winslade, Dictionary of Clinical Research, 1992) AUC,Area Under Curves,Curve, Area Under,Curves, Area Under,Under Curve, Area,Under Curves, Area

Related Publications

Jun Chen, and Wei Lu, and Xin-guo Jiang, and Zheng-xing Rong, and Xia Huang, and Hong-zhuan Chen
Single-dose pharmacokinetics and safety of iptakalim hydrochloride in Chinese healthy volunteers.
March 2012, The Journal of pharmacy and pharmacology,
Jun Chen, and Wei Lu, and Xin-guo Jiang, and Zheng-xing Rong, and Xia Huang, and Hong-zhuan Chen
Pharmacokinetics of lofexidine hydrochloride in healthy volunteers.
January 2009, Journal of pharmaceutical sciences,
Jun Chen, and Wei Lu, and Xin-guo Jiang, and Zheng-xing Rong, and Xia Huang, and Hong-zhuan Chen
[Pharmacokinetics of injected cefozopran hydrochloride in healthy volunteers].
September 2012, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition,
Jun Chen, and Wei Lu, and Xin-guo Jiang, and Zheng-xing Rong, and Xia Huang, and Hong-zhuan Chen
Pharmacokinetics and bioequivalence study of two cetirizine hydrochloride formulations in healthy Chinese male volunteers.
January 2009, Arzneimittel-Forschung,
Jun Chen, and Wei Lu, and Xin-guo Jiang, and Zheng-xing Rong, and Xia Huang, and Hong-zhuan Chen
Clinical pharmacology of sibutramine hydrochloride (BTS 54524), a new antidepressant, in healthy volunteers.
November 1988, British journal of clinical pharmacology,
Jun Chen, and Wei Lu, and Xin-guo Jiang, and Zheng-xing Rong, and Xia Huang, and Hong-zhuan Chen
Pharmacokinetics of febuxostat in healthy Chinese volunteers.
October 2012, Arzneimittel-Forschung,
Jun Chen, and Wei Lu, and Xin-guo Jiang, and Zheng-xing Rong, and Xia Huang, and Hong-zhuan Chen
[Pharmacokinetics of meloxicam in healthy Chinese volunteers].
January 2001, Yao xue xue bao = Acta pharmaceutica Sinica,
Jun Chen, and Wei Lu, and Xin-guo Jiang, and Zheng-xing Rong, and Xia Huang, and Hong-zhuan Chen
Pharmacokinetics of clopidogrel in healthy Chinese volunteers.
September 2012, Die Pharmazie,
Jun Chen, and Wei Lu, and Xin-guo Jiang, and Zheng-xing Rong, and Xia Huang, and Hong-zhuan Chen
Pharmacokinetics of leflunomide in Chinese healthy volunteers.
June 2002, Acta pharmacologica Sinica,
Jun Chen, and Wei Lu, and Xin-guo Jiang, and Zheng-xing Rong, and Xia Huang, and Hong-zhuan Chen
[Pharmacokinetics of deflazacort tablets in healthy Chinese volunteers].
June 2014, Yao xue xue bao = Acta pharmaceutica Sinica,
Copied contents to your clipboard!